Download PDF

Other users also viewed these articles

Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines Haline Tereza Matias Lima Costa; Arlan Peres Florencio; Priscilla Karilline do Vale Bezerra; Jéssica Escorel Chaves Cavalcanti; Tatiana Xavier Costa; Flavia Evelyn Medeiros Fernandes; Martins Rand Randall;
An Pediatr (Barc). 2021;94:153-60
Clinical features and risk factors associated with prenatal exposure to drugs of abuse Antonia Roca; Pilar Jarque; Isabel Gomila; Emilia Marchei; Roberta Tittarelli; Miguel Ángel Elorza; Pilar Sanchís; Bernardino Barceló;
An Pediatr (Barc). 2021;95:307-20
Off-label pediatric medicines in Spain Roi Piñeiro Pérez; Esmeralda Núñez Cuadros; Belén Rodríguez Marrodán; Raquel Escrig Fernández; María Ángeles Gil Lemus; Santiago Manzano Blanco; Cristina Calvo;
An Pediatr (Barc). 2021;94:188.e1-9